Comparative Pharmacology
Head-to-head clinical analysis: BRETYLIUM TOSYLATE versus IBUTILIDE FUMARATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: BRETYLIUM TOSYLATE versus IBUTILIDE FUMARATE.
BRETYLIUM TOSYLATE vs IBUTILIDE FUMARATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Bretylium tosylate is a class III antiarrhythmic agent that prolongs the action potential duration and refractory period by blocking potassium channels. It also initially causes norepinephrine release, leading to transient hypertension and increased contractility, followed by adrenergic neuron blockade, resulting in hypotension and reduced contractility.
Ibutilide fumarate is a Class III antiarrhythmic agent that prolongs the atrial and ventricular refractory period by blocking the rapid component of the delayed rectifier potassium current (IKr) and also enhances the slow inward sodium current (INa), resulting in prolongation of the action potential duration and effective refractory period.
For ventricular tachycardia/fibrillation: 5-10 mg/kg IV bolus over 1-2 minutes, may repeat every 15-30 minutes up to 30 mg/kg total. Maintenance: 5-10 mg/kg IV every 6 hours or 0.5-2 mg/min continuous infusion. Intramuscular: 5-10 mg/kg undiluted, may repeat every 1-2 hours.
1 mg (10 mL of 0.1 mg/mL solution) IV infusion over 10 minutes; if arrhythmia persists after 10 minutes post-infusion, a second 1 mg dose may be administered. For patients weighing <60 kg, use 0.01 mg/kg.
None Documented
None Documented
5-10 hours; prolonged in renal impairment (up to 30 hours)
Terminal elimination half-life is 2–12 hours (mean 6 hours). In atrial fibrillation/flutter, the clinically effective half-life allowing for arrhythmia conversion is approximately 2–4 hours due to rapid redistribution.
Renal: ~80% unchanged; biliary/fecal: <1%
Primarily hepatic metabolism; less than 10% excreted unchanged in urine. Biliary/fecal excretion accounts for approximately 20% of total clearance.
Category C
Category A/B
Antiarrhythmic (Class III)
Antiarrhythmic (Class III)